| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030983998 |
| P356 | DOI | 10.1007/S00417-007-0737-8 |
| P698 | PubMed publication ID | 18193265 |
| P2093 | author name string | Norbert Pfeiffer | |
| Franz H Grus | |||
| Stephanie C Joachim | |||
| Jan Reichelt | |||
| Simone Berneiser | |||
| P2860 | cites work | The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 |
| Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event | Q28186287 | ||
| Early glial responses after acute elevated intraocular pressure in rats | Q30884327 | ||
| Autoantibodies as predictors of disease | Q34319804 | ||
| A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma | Q34377317 | ||
| Circulating autoantibodies to neuronal and glial filament proteins in autism | Q34440250 | ||
| Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. | Q34653997 | ||
| The impact of ocular blood flow in glaucoma | Q34768692 | ||
| General network of natural autoantibodies as immunological homunculus (Immunculus). | Q35215771 | ||
| Number of people with glaucoma worldwide | Q37320324 | ||
| Computer-supported analysis (MegaBlot) of allopurinol-induced changes in the autoantibody repertoires of rats suffering from experimental lens-induced uveitis. | Q39445332 | ||
| Complex autoantibody repertoires in patients with glaucoma | Q39677385 | ||
| Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States | Q40347336 | ||
| Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia | Q40735178 | ||
| Anti-basal ganglia antibody abnormalities in Sydenham chorea | Q42437920 | ||
| Expression of glial fibrillary acidic protein and glutamine synthetase by Müller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor | Q42520028 | ||
| Serum autoantibody against glutathione S-transferase in patients with glaucoma | Q43592214 | ||
| Open-angle glaucoma clinical presentation and management | Q43861156 | ||
| Analysis of autoantibody repertoires in sera of patients with glaucoma. | Q44709853 | ||
| Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens | Q46440971 | ||
| Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension | Q46694030 | ||
| Changes in the expression of specific Müller cell proteins during long-term retinal detachment | Q46830650 | ||
| Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis | Q48216573 | ||
| The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up | Q48486725 | ||
| Evaluation of a rat model of experimental autoimmune encephalomyelitis with human MBP as antigen. | Q51832537 | ||
| Multivariate statistical comparison of autoantibody-repertoires (western blots) by discriminant analysis. | Q52341082 | ||
| Serum autoantibodies to heat shock proteins in glaucoma patients from Japan and the United States. | Q53898771 | ||
| Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. | Q53913933 | ||
| Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. | Q53928682 | ||
| Autoantibodies to small heat shock proteins in glaucoma. | Q53943140 | ||
| Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis | Q59273850 | ||
| Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study | Q59273880 | ||
| A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease | Q68834759 | ||
| Some thoughts on the structural basis of internal imagery | Q69647661 | ||
| Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin | Q70285218 | ||
| Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid | Q71614482 | ||
| Programmed cell death of retinal ganglion cells during experimental glaucoma | Q71735807 | ||
| Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma | Q72016826 | ||
| Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis | Q72650116 | ||
| Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations | Q73086963 | ||
| Immunoglobulins and Antibodies | Q73247969 | ||
| Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis | Q73943317 | ||
| Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma | Q74188653 | ||
| Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis | Q74431949 | ||
| Striatal antibodies in children with Tourette's syndrome: multivariate discriminant analysis of IgG repertoires | Q74431959 | ||
| A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis | Q78025853 | ||
| Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein | Q78109046 | ||
| Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients | Q78332731 | ||
| Autoantibodies in Systemic Lupus Erythematosus — There before You Know It | Q79171861 | ||
| Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus | Q79171865 | ||
| Neurofilament and glial fibrillary acidic protein in multiple sclerosis | Q80980689 | ||
| P433 | issue | 4 | |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 573-580 | |
| P577 | publication date | 2008-01-12 | |
| P1433 | published in | Graefe's Archive for Clinical and Experimental Ophthalmology | Q15757667 |
| P1476 | title | Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens | |
| P478 | volume | 246 |
| Q36828359 | A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration |
| Q51747222 | Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma. |
| Q45926332 | Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. |
| Q64120727 | Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA) |
| Q90093482 | Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire |
| Q50090578 | Autoimmunity and glaucoma |
| Q38770795 | Biomarkers for glaucoma: from the lab to the clinic |
| Q36167338 | Course of serum autoantibodies in patients after acute angle-closure glaucoma attack |
| Q38663505 | Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model |
| Q51410147 | Elevated Regulatory T Cell Levels in Glaucoma Patients in Comparison to Healthy Controls. |
| Q42881025 | Enhanced Characterization of Serum Autoantibody Reactivity Following HSP 60 Immunization in a Rat Model of Experimental Autoimmune Glaucoma |
| Q34603641 | Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina |
| Q38491589 | Expression profiling in glaucomatous human lamina cribrosa cells based on graph-clustering approach |
| Q47611400 | HSP27 immunization reinforces AII amacrine cell and synapse damage induced by S100 in an autoimmune glaucoma model |
| Q90206205 | Immune Mediated Degeneration and Possible Protection in Glaucoma |
| Q36487609 | Immune regulation toward immunomodulation for neuroprotection in glaucoma |
| Q39366776 | Immune response against ocular tissues after immunization with optic nerve antigens in a model of autoimmune glaucoma |
| Q92069863 | Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model |
| Q36299887 | Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma. |
| Q36234565 | Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage |
| Q50878352 | Modulation of the immune system for the treatment of glaucoma. |
| Q51581253 | Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture. |
| Q92073710 | Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review |
| Q33940166 | Normal versus high tension glaucoma: a comparison of functional and structural defects |
| Q47894675 | Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG). |
| Q88323880 | Plasma citrate concentration: a possible biomarker for glaucoma in children |
| Q35676010 | Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway |
| Q53278039 | Relationship between retinal morphological findings and autoantibody profile in primary Sjögren's syndrome. |
| Q27334415 | Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens |
| Q53647549 | S100 alone has the same destructive effect on retinal ganglion cells as in combination with HSP 27 in an autoimmune glaucoma model. |
| Q42748914 | Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model. |
| Q45786530 | Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper |
| Q64079184 | T-Lymphocyte Subset Distribution and Activity in Patients With Glaucoma |
| Q42366656 | The diagnostic value of white blood cell, neutrophil, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in patients with primary angle closure glaucoma |
| Q34388254 | The immune response in glaucoma: a perspective on the roles of oxidative stress |
| Q39167734 | The potential impact of recent insights into proteomic changes associated with glaucoma |
| Q33358097 | Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. |
| Q42678146 | Valosin-Containing Protein is a Novel Autoantigen in Patients with Glaucoma |
| Q33720688 | Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma |
| Q35111136 | γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway |
Search more.